Meningitis after injection of intrathecal baclofen

Anesthesia and Analgesia

Volumn 82, Issue 6, 1996, Pages 1297-1299

  Naveira, Francisco A ^a,b   Speight, Kevin L ^a   Rauck, Richard L ^a   Carpenter, Randall L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CEFTAZIDIME; DIAZEPAM; GENTAMICIN; VANCOMYCIN;

ADULT; ARTICLE; ASEPTIC MENINGITIS; CASE REPORT; CAUDA EQUINA; CEREBROSPINAL FLUID EXAMINATION; EPIDURAL CATHETER; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LUMBAR PUNCTURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPASTICITY;

ADULT; BACLOFEN; HUMANS; INJECTIONS, SPINAL; MALE; MENINGITIS, ASEPTIC; SUBARACHNOID SPACE;

EID: 0029979127     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199606000-00036     Document Type: Article

References (23)

1. Wilson PR, Yaksh TL. Badofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 1978;51:323-30.
2. Yaksh TL, Reddy SV. Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, alphaadrenergic agonists and baclofen. Anesthesiology 1981;54:451-67.
3. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1:1078.
4. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985;2:125-7.
5. Lazorthes Y, Sallerin-Caute B, Verdie JC, et al. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402.
6. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-21.
7. Latash ML, Penn RD, Corcos DM, Gottlieb GL. Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 1990;72:388-92.
8. Meythaler JM, Steers WD, Tuel SM, et al. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 1992;71:321-7.
9. Sabbe MB, Grafe MR, Pfeifer BL, et al. Toxicology of baclofen continuously infused into the spinal intrathecal space of the dog. Neurotoxicology 1993;14:397-410.
10. Price GW, Wilkin GP, Turnbull MJ, Bowery NG. Are baclofen-sensitive GABA-beta receptors present on primary afferent terminals of the spinal cord? Nature 1984;307:71-4.
11. Davidoff RA. Antispasticity drugs: mechanism of action. Ann Neurol 1985;17:107-16.
12. Young RR, Delwaide PJ. Drug therapy: spasticity. N Engl J Med 1981;304:96-9.
13. Katz RT. Managemetn of spasticity. Am J Phys Med Rehabil 1988;67:108-16.
14. Lishner M, Perrin RG, Feld R, et al. Complications associated with Ommaya reservoirs in patients with cancer. Arch Intern Med 1990;150:173-6.
15. Teddy P, Jamous A, Gardner B, et al. Complications of intrathecal baclofen delivery. Br J Neurosurg 1992;6:115-8.
16. Patterson V, Watt M, Byrnes D, et al. Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump. J Neurol Neurosurg Psychiatry 1994;57:582-5.
17. Dicpinigaitis PV, Nierman DM, Miller A. Baclofen-induced bronchoconstriction. Ann Pharmacother 1993;27:883-4.
18. Ryan DM, Blumenthal FS. Baclofen-induced dyskinesia. Arch Phys Med Rehabil 1993;74:766-7.
19. Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995;8:230-4.
20. Roy CW, Wakefield IR. Baclofen pseudopsychosis: case report. Paraplegia 1986;24:318-21.
21. Yassa RY, Iskandar HL. Baclofen-induced psychosis: two cases and a review. J Clin Psychiatry 1988;49:318-20.
22. Johnson RT. Viral meningitis and encephalitis. In: Wyngaarden JB, Smith LH Jr, eds. Cecil textbook of medicine. 16th ed. Philadelphia: WB Saunders, 1982:2085-9.
23. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236-40.